𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antiretroviral therapy and liver fibrosis in HIV-infected patients with chronic hepatitis C

✍ Scribed by Juan Macías; José A. Mira; Salvador Vergara; Juan A. Pineda

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
86 KB
Volume
42
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Steatosis and progression of fibrosis in
Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection
✍ Ponni Perumalswami; David E. Kleiner; Glen Lutchman; Theo Heller; Brian Borg; Yo 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB 👁 1 views

Hepatic steatosis is common in patients with chronic hepatitis C (CHC) and is reported to be a risk factor for progression of fibrosis. The aims of this study were to evaluate the interactions between hepatic steatosis and fibrosis in a well-defined cohort of patients with CHC. The computerized path

Hepatitis C viral quasispecies and liver
Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection
✍ J Hayashi; Y Kishihara; K Yamaji; N Furusyo; T Yamamoto; Y Pae; Y Etoh; H Ikemat 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 1 views

To clarify the virological differences in patients with chronic hepatitis C virus (HCV) infection with and without liver damage, we assessed HCV markers in 306 patients from a rural area of Japan. Genotypes of HCV RNA were determined by polymerase chain reaction, and levels of RNA were determined by

Clinical progression of hepatitis C viru
Clinical progression of hepatitis C virus–related chronic liver disease in human immunodeficiency virus–infected patients undergoing highly active antiretroviral therapy
✍ Juan A. Pineda; José A. García-García; Manuela Aguilar-Guisado; María J. Ríos-Vi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB 👁 1 views

Little is known about the natural history of liver disease in human immunodeficiency virus (HIV)/hepatitis C virus (HCV)-coinfected subjects under highly active antiretroviral therapy (HAART). The objectives of this study were to obtain information about the mortality, the incidence of hepatic decom

The effect of antiretroviral therapy on
The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection
✍ Shruti H. Mehta; David L. Thomas; Michael Torbenson; Sherilyn Brinkley; Lisa Mir 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB 👁 1 views

In the era of antiretroviral therapy (ART), liver disease has emerged as an important cause of death among persons with human immunodeficiency virus (HIV)/hepatitis C virus (HCV) coinfection. The objective of this study was to estimate the burden of liver disease and evaluate determinants of liver f

Simple blood tests as noninvasive marker
Simple blood tests as noninvasive markers of liver fibrosis in hemodialysis patients with chronic hepatitis C virus infection
✍ Leonardo L. Schiavon; Janaína L. N. Schiavon; Roberto J. Carvalho Filho; Juliana 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB 👁 1 views

HCV infection is common among patients with end-stage renal disease (ESRD) on hemodialysis, and it has been considered an independent risk factor for mortality in this setting. Although liver biopsy in ESRD patients with HCV infection is useful before kidney transplantation, it carries a high risk o